.Pharmacolibrary.Drugs.V_Various.V10X_OtherTherapeuticRadiopharmaceuticals.V10XA01_SodiumIodide131i.SodiumIodide131i .Pharmacolibrary.Drugs.V_Various.V10X_OtherTherapeuticRadiopharmaceuticals.V10XA01_SodiumIodide131i.SodiumIodide131i| name: | SodiumIodide131i | |
| ATC code: | V10XA01 | route: | oral |
| compartments: | 1 | |
| dosage: | 370 | mg |
| volume of distribution: | 23 | L |
| clearance: | 1.2 | L/h |
| other parameters in model implementation | ||
Sodium iodide (131I) is a radiopharmaceutical used primarily in the diagnosis and treatment of thyroid disorders, including thyroid cancer and hyperthyroidism, due to its uptake by thyroid tissue. It is an FDA-approved agent and remains standard of care for these indications.
Estimated typical pharmacokinetic parameters for adult euthyroid (normal thyroid function) individuals after oral administration.